Literature DB >> 2087939

Apolipoprotein profile in type II diabetic patients with and without coronary heart disease.

C M Barbagallo1, M R Averna, S Amato, G Marino, M Labisi, A C Rao, M Barbagallo, G F Cupidi, A Notarbartolo.   

Abstract

Diabetes mellitus is frequently associated with lipid metabolism abnormalities. In the present study the lipid and apolipoprotein profiles have been compared in type II diabetic subjects with (n = 30) and without (n = 30) coronary heart disease (CHD). All subjects were studied after good metabolic control had been achieved. Significant differences in plasma lipids and apolipoproteins were seen in diabetic patients with CHD in comparison with diabetics without CHD. Patients with CHD presented higher total cholesterol, triglyceride, LDL-cholesterol, apo B, apo CII and apo CIII levels and total cholesterol/HDL-cholesterol and LDL-cholesterol HDL-cholesterol ratios and lower HDL-cholesterol values and apo A1/apo B ratio than the patients without CHD. The same findings were found in females; while male subjects with CHD had significantly increased total cholesterol, LDL-cholesterol and apo B levels and total cholesterol/HDL-cholesterol and LDL-cholesterol/HDL-cholesterol ratios and significantly decreased apo A1/apo B ratio compared with males without CHD. These findings support the concept that the apolipoprotein profile plays a remarkable role as risk factor for CHD in type II diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2087939     DOI: 10.1007/BF02580943

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN: 0001-5563


  26 in total

1.  A METHODOLOGICAL STUDY OF THE ENZYMATIC DETERMINATION OF GLUCOSE IN BLOOD.

Authors:  M HJELM; C H DE VERDIERCH
Journal:  Scand J Clin Lab Invest       Date:  1963       Impact factor: 1.713

2.  Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study.

Authors:  M J Garcia; P M McNamara; T Gordon; W B Kannel
Journal:  Diabetes       Date:  1974-02       Impact factor: 9.461

3.  Platelet function in hyperlipoproteinemia.

Authors:  A C Carvalho; R W Colman; R S Lees
Journal:  N Engl J Med       Date:  1974-02-21       Impact factor: 91.245

4.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

5.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

6.  Platelet function in patients with type 2 diabetes mellitus: the effect of glycaemic control.

Authors:  G Davì; M Averna; I Catalano; C M Barbagallo; E Giovenco; A Carroccio; A Notarbartolo; A Strano
Journal:  Diabetes Res       Date:  1989-01

7.  Serum lipids, lipoproteins, and apolipoproteins and the excessive occurrence of coronary heart disease in non-insulin-dependent diabetic patients.

Authors:  T Rönnemaa; M Laakso; V Kallio; K Pyörälä; J Marniemi; P Puukka
Journal:  Am J Epidemiol       Date:  1989-10       Impact factor: 4.897

8.  Lipoprotein patterns in diet, sulphonylurea, and insulin treated diabetics.

Authors:  H J Lisch; S Sailer
Journal:  Diabetologia       Date:  1981-02       Impact factor: 10.122

9.  Lipid and lipoprotein abnormalities associated with coronary heart disease in patients with insulin-dependent diabetes mellitus.

Authors:  M Laakso; K Pyörälä; H Sarlund; E Voutilainen
Journal:  Arteriosclerosis       Date:  1986 Nov-Dec

10.  Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group.

Authors: 
Journal:  Diabetes       Date:  1979-12       Impact factor: 9.461

View more
  1 in total

1.  Correlation of serum alanine aminotransferase and aspartate aminotransferase with coronary heart disease.

Authors:  Jianying Shen; Jingying Zhang; Jing Wen; Qiang Ming; Ji Zhang; Yawei Xu
Journal:  Int J Clin Exp Med       Date:  2015-03-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.